MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma

At the time of diagnosis, 60% of patients with head and neck squamous cell carcinoma (HNSCC) present tumors in an advanced stage (III-IV) of disease and 80% will relapse within the first two years post-treatment, due to their frequent radio(chemo)resistance. To identify new molecular targets and com...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonnin, Nathalie, Armandy, Emma, Carras, Julien, Ferrandon, Sylvain, Battiston-Montagne, Priscillia, Aubry, Marc, Guihard, Sébastien, Meyronet, David, Foy, Jean-Philippe, Saintigny, Pierre, Ledrappier, Sonia, Jung, Alain, Rimokh, Ruth, Rodriguez-Lafrasse, Claire, Poncet, Delphine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190076/
https://www.ncbi.nlm.nih.gov/pubmed/27281619
http://dx.doi.org/10.18632/oncotarget.9829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190076/
https://www.ncbi.nlm.nih.gov/pubmed/27281619
http://dx.doi.org/10.18632/oncotarget.9829

Ejemplares similares